JG

Jojibabu Garikipudi

Active Director Managing Director DIN 09044932
DIN 09044932 First appointment Feb 2021 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Jojibabu Garikipudi

Data last updated:

Jojibabu Garikipudi is a Managing Director at Charaka Laboratories Private Limited (since 2021). The company operates in Pharma.

DIN 09044932
Primary Designation Managing Director
Industry Pharma
First Appointment 02 Feb 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Charaka Laboratories Private Limited U24239TG2021PTC148216
Managing Director02 Feb 20212021Active

Board colleagues of Jojibabu Garikipudi

NameDINCompanyDesignation
Angadala Venkateswaramma09044931Charaka Laboratories Private LimitedDirector

Directorship timeline

Open interactive timeline →
Charaka Laboratories Private Limited
Premium access

Shareholding and investment profile for Jojibabu Garikipudi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jojibabu Garikipudi

Jojibabu Garikipudi currently holds 1 directorship: Charaka Laboratories Private Limited (Managing Director, since 02 Feb 2021).

Jojibabu Garikipudi was first appointed on 02 Feb 2021 as Managing Director at Charaka Laboratories Private Limited.

The current boards of Jojibabu Garikipudi's companies include Angadala Venkateswaramma (Charaka Laboratories Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available